L. Garetto

868 total citations
18 papers, 710 citations indexed

About

L. Garetto is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Garetto has authored 18 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hematology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Garetto's work include Hematopoietic Stem Cell Transplantation (6 papers), Platelet Disorders and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). L. Garetto is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Platelet Disorders and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). L. Garetto collaborates with scholars based in Italy, United Kingdom and Switzerland. L. Garetto's co-authors include Massimo Aglietta, Wanda Piacibello, F Sanavio, Franca Fagioli, Massimo Berger, A Severino, Loretta Gammaitoni, Alessandra Danè, Alessandra Stacchini and L Pegoraro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

L. Garetto

17 papers receiving 696 citations

Peers

Countries citing papers authored by L. Garetto

Since Specialization

Citations

This map shows the geographic impact of L. Garetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Garetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Garetto more than expected).

Fields of papers citing papers by L. Garetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Garetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Garetto. The network helps show where L. Garetto may publish in the future.

Co-authorship network of co-authors of L. Garetto

This figure shows the co-authorship network connecting the top 25 collaborators of L. Garetto. A scholar is included among the top collaborators of L. Garetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Garetto. L. Garetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Assessing the role of colonic and other anatomical sites uptake by [¹⁸F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with advanced non‐small cell lung cancer treated with first‐line immune checkpoint inhibitors 2023 ·Thoracic Cancer ·Alessio Rizzo, Ornella Cantale, (unknown), L. Garetto, Manuela Racca, Tiziana Venesio, (unknown), Silvia Novello, Vanesa Gregorc, Giuseppe Luigi Banna	7
2	International Survey on Frailty Assessment in Patients with Cancer 2022 ·The Oncologist ·Giuseppe Luigi Banna, Ornella Cantale, (unknown), Nicolò Matteo Luca Battisti, (unknown), (unknown), (unknown), Giuseppe Maltese, L. Garetto, Alfredo Addeo, Fábio Gomes	9
3	Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer 2022 ·Current Oncology Reports ·Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Édouard Auclin, L. Garetto, Laura Mezquita, Alfredo Addeo	11
4	Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients 2021 ·Cancers ·Enrico Berrino, Alberto Bragoni, Laura Annaratone, Elisabetta Fenocchio, Fabrizio Carnevale‐Schianca, L. Garetto, Massimo Aglietta, Ivana Sarotto, Laura Casorzo, Tiziana Venesio, Anna Sapino, Caterina Marchiò	5
5	Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report 2016 ·BMC Cancer ·Elisabetta Fenocchio, Ilaria Depetris, Delia Campanella, L. Garetto, (unknown), Danilo Galizia, Giovanni Grignani, Massimo Aglietta, Francesco Leone	7
6	Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone 2007 ·Annals of Oncology ·Silvia Novello, Paolo Bruzzi, (unknown), (unknown), A Masotti, G. Michetti, (unknown), Santi Barbera, Mario Spatafora, L. Garetto, Paola Mazzanti, (unknown), Giovanni Selvaggi, Lucio Crinò, Giorgio V. Scagliotti	15
7	The 41st Annual Meeting of The American Society of Clinical Oncology 2005 ·Expert Opinion on Pharmacotherapy ·Filippo Montemurro, Giorgio Valabrega, L. Garetto, (unknown), Giovanni Grignani, Cinzia Ortega, Francesco Leone, Riccardo Ponzone, Massimo Aglietta	8
8	O-096 Phase III study in patients with stage IV non small-cell lungcancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone 2005 ·Lung Cancer ·Silvia Novello, C. Barone, A Masotti, (unknown), G. Michetti, (unknown), (unknown), L. Garetto, A Maestri, Mario Spatafora	0
9	Early data of phase III study in patients (pts) with stage IV non-small-cell lung cancer (NSCLC) treated with two cycles of cisplatin/gemcitabine followed by a randomization to three additional cycles of the same combination or gemcitabine alone 2004 ·Journal of Clinical Oncology ·Silvia Novello, C. Barone, (unknown), G. Michetti, (unknown), (unknown), A Masotti, L. Garetto, Paolo Bruzzi, Giorgio V. Scagliotti	1
10	The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation 2003 ·Experimental Hematology ·Alessandro Cignetti, Antonella Vallario, Ilaria Roato, Paola Circosta, Giuliana Strola, Cristina Scielzo, Bernardino Allione, L. Garetto, Federico Caligaris‐Cappio, Paolo Ghia	28
11	Ex vivo expansion of megakaryocytes 2000 ·Transfusion Science ·Wanda Piacibello, L. Garetto, Massimo Aglietta	5
12	Ex Vivo Expansion of Cord Blood Progenitors 1998 ·Vox Sanguinis ·Wanda Piacibello, F Sanavio, A Severino, L. Garetto, Alessandra Danè, Loretta Gammaitoni, Massimo Aglietta	13
13	Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation 1998 ·Leukemia ·Wanda Piacibello, F Sanavio, L. Garetto, A Severino, Alessandra Danè, Loretta Gammaitoni, Massimo Aglietta	111
14	The role of c&hyphen;Mpl ligands in the expansion of cord blood hematopoietic progenitors 1998 ·Stem Cells ·Wanda Piacibello, F Sanavio, L. Garetto, (unknown), (unknown), Loretta Gammaitoni, Massimo Aglietta	13
15	Megakaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional c-mpl 1997 ·Leukemia ·Wanda Piacibello, F Sanavio, (unknown), L. Garetto, A Severino, (unknown), Giulia Dragonetti, Massimo Aglietta, Luigi Pegoraro	13
16	Extensive Amplification and Self-Renewal of Human Primitive Hematopoietic Stem Cells From Cord Blood 1997 ·Blood ·Wanda Piacibello, F Sanavio, L. Garetto, (unknown), (unknown), (unknown), Franca Fagioli, Massimo Berger, Massimo Aglietta	363
17	The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. 1996 ·PubMed ·Wanda Piacibello, L. Garetto, F Sanavio, A Severino, (unknown), Alessandra Stacchini, Giulia Dragonetti, Massimo Aglietta	29
18	Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors 1995 ·Blood ·Wanda Piacibello, (unknown), F Sanavio, (unknown), A Severino, L. Garetto, Alessandra Stacchini, L Pegoraro, Massimo Aglietta	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact